Chemclone India Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Ebitda
- Net Worth
- Total Assets 5.68%
About Chemclone India
Chemclone India Private Limited (CIPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 February 2017 (Seven years and 11 months 25 days old ). Its registered office is in Bharuch, Gujarat.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Aditya Tulsyan, Rohan Mahipal, and Raju Mahipal serve as directors at the Company.
Company Details
-
LocationBharuch, Gujarat
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100GJ2017PTC095430
-
Company No.
095430
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
06 Feb 2017
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Chemclone India?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rohan Mahipal
|
Director | 06-Feb-2017 | Current |
|
Aditya Tulsyan
|
Director | 06-Feb-2017 | Current |
|
Raju Mahipal
|
Additional Director | 18-Jul-2022 | Current |
Financial Performance of Chemclone India.
Chemclone India Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chemclone India?
In 2020, Chemclone India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Sommet Capital LlpAditya Tulsyan is a mutual person
-
Qna Research Llp
Aditya Tulsyan is a mutual person
-
Radar Commercials Private Limited
Aditya Tulsyan is a mutual person
-
Chicky Traders Pvt Ltd
Aditya Tulsyan is a mutual person
-
Vidhika Niwas Private Limited
Aditya Tulsyan is a mutual person
-
Vikas Consultants Pvt Ltd
Aditya Tulsyan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Chemclone India?
Unlock and access historical data on people associated with Chemclone India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chemclone India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chemclone India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.